Sun Life Financial’s Q2 2026 Call: Stop-Loss Pricing Doubts, Dental Medicaid Woes, and Earnings Growth Drivers Don’t Match

Date of Call: Aug 7, 2026

Financials Results

• Revenue: Underlying net income of $1.12B, up from $1.02B last year; underlying EPS of $2.02, up 13% YOY.
• EPS: $2.02 per diluted share, up 13% YOY.

Business Commentary:

Strong Financial Performance:

• Sun Life Financial reported underlying net income of $1.12 billion, up from $1.02 billion last year, with underlying EPS of $2.02, reflecting a 13% increase over the prior year.
• The growth was driven by strong earnings across Canada, Asia, and the U.S., as well as continued progress in strategic priorities like asset management.

Digital Transformation and AI Adoption:

• Sun Life made significant progress in its digital transformation, including launching a proprietary agentic AI platform and enhancing the My Sun Life app with integrated health capabilities.
• These initiatives are part of a broader strategy to improve client experiences, operate more efficiently, and scale businesses responsibly.

Asset Management Growth:

• Sun Life Asset Management reported underlying net income of $262 million, a 4% year-over-year increase, driven by strong capital raising and deployment activities.
• Growth was supported by improved fundraising, particularly in private credit, and strategic acquisitions like the large fixed income mandate in India.

Asia Market Expansion:

• Asia's underlying net income increased by 21% over the prior year, driven by robust organic growth and improved credit experience.
• The growth was attributed to strong insurance sales, particularly in Hong Kong and Indonesia, and a significant increase in advisors.

U.S. Stop-Loss and Dental Business:

• The U.S. stop-loss business saw a 86% increase in sales year-over-year, reflecting strong underwriting and pricing discipline.
• In contrast, the dental business faced challenges, primarily due to a 9% decline in Medicaid membership, but efforts to improve profitability through pricing discipline and commercial growth are underway.

Sentiment Analysis:

Overall Tone: Positive

• CEO stated, "We delivered strong second quarter results with double-digit underlying EPS growth." CFO noted, "We are very pleased with our second quarter results, which demonstrate the earnings power of our business." Strong performance across Canada, Asia, and U.S., with asset management building momentum.

Q&A:

• Question from Gabrielle Deschain (National Bank): On the U.S. business, both the stop-loss and the dental. On stop-loss, I forget what page in the slides, it says unfavorable experience due to seasonal reserve build. ... I just want to get a sense for how much more business is there to shed and what's the timeline for that, like the intermediated or brokered Medicaid business?
  Response: Unfavorable but expected seasonal reserve build in stop-loss; overall business performing well. For dental, Medicaid membership down 9%; ongoing volume headwinds expected this year, with focus on shifting to a more profitable commercial mix over the next 1-2 years.

• Question from Mike Ward (UBS): I was just wondering if you could discuss the stop-loss sales result. ... I'm just wondering if you could kind of characterize the competitive environment and is it easy you know is it easier to win new business given the hard market...
  Response: Disciplined pricing and underwriting, advanced analytics, and differentiated capabilities position Sun Life well in the hardening market, benefiting from risk selection and cost containment focus.

• Question from Doug Young (Desjardins): Maybe just going to Canada, can you, Jessica, talk a little bit about the experience this quarter, which was favorable. ... Is this division punching above its weight, or just trying to get a sense of the sustainability of this...
  Response: Favorable insurance experience driven by sustained investments in case management and digitization. Positive experience expected to continue; Canada's overall earnings growth of 15% in H1 driven by insurance, CSM growth, health, and wealth business gains.

• Question from David Andridge (Jefferies): Just wanted to follow up on Doug's question around the experience gains in Canada. ... And just, you know, some of your peers have experienced some headwinds from long-term disability experience...
  Response: Expect positive insurance experience to continue with quarterly fluctuations. Addressing long-term disability trends through sustained investments in people, processes, and capabilities, including disability management rollouts.

• Question from Nick Liu (Evercore): My first one was a quick follow-up on Asia. Should I read the earlier comment as in the MCV business represent about 30% of total sales out of Hong Kong? And how have the local bank insurance partners been reacting to the updates...
  Response: Yes, MCV represents about 30% of Hong Kong sales. Bank assurance partners, like Da Sing, are maintaining diligence on account openings due to new requirements, but relationships remain strong.

• Question from Paul Holden (CIBC): I want to continue with the line of questioning on stop loss. So premiums are up 25% year over year. You say that margins or loss ratios in line with your expectation. ... So unless you're getting more conservative on IBNR, I'm not really sure why we're not seeing more earnings growth out of stop loss.
  Response: Solid earnings growth is being seen, but offset by a decline in employee benefits business from a record quarter last year, which included favorable experience and one-time items that did not recur.

• Question from Tom McKinnon (BMO Capital): First on... Asia, just with respect to your high net worth business there. ... what proportion of these high net worth clients... would be from China... Would that have any impact...
  Response: MCV clients make up about 10% of the high-net-worth business; overall impact expected to be minimal given the international client base.

• Question from Tom McKinnon (BMO Capital): And then just with respect to SLC, ... if I look in the in the quarter here, ... flows are better, but the fee-related revenue, fee-related earnings are kind of flat year over year. What would you point to to give you confidence that the setup here is good?
  Response: Confidence based on strong performance in core strategies (real estate, private credit, infrastructure), expected wealth business growth, and now operating as a unified platform to pursue expense efficiencies and accelerate growth.

• Question from Mario Mendonca (TD Securities): ... Did you lay out the proportion of Hong Kong sales that relate to MCV?
  Response: Yes, MCV represents about 30% of Hong Kong sales.

• Question from Mario Mendonca (TD Securities): ... When you see the decline in CSM generated in the quarter relative to the sales, it immediately makes me think that the pricing environment, the pricing was different this quarter from the previous year. So where I'm going with this is, were there any pricing concessions or specials on particular products in the quarter?
  Response: Margin differences are due to product evolution over the last year, not specific to this quarter. Current mid-30% margins are appropriate in the competitive environment, though could change.

• Question from Mario Mendonca (TD Securities): ... Is this the kind of business that benefits from consolidation, or are you better off watching your competitors de-emphasize the business than taking share at margins you prefer? Is this an organic story, or does it lend itself to deals?
  Response: Focus is on organic growth leveraging differentiated capabilities and proprietary analytics; consolidation is not a priority.

Contradiction Point 1

U.S. Stop-Loss Business Experience and Pricing Confidence

Contradiction on the early assessment of the 2026 business cohort experience.

Nick Liu (Evercore) - Nick Liu (Evercore)

2026Q2: The company is carefully monitoring the emerging experience on the 1-1-26 cohort (15% complete). Underlying technical analysis and emerging actual experience give confidence in the pricing approach. - David (U.S. Business Leader)

Regarding the U.S. stop-loss business, do you have an early view on rate increases for 1-1-27 and whether the favorable experience on 2026 books aligns with peer performance? - Mike Ward (UBS)

2026Q2: The 1-1-25 cohort is 97% complete and in line with expectations, and the company is seeing improved pricing on new business. - David (U.S. Business Leader)

Contradiction Point 2

U.S. Stop-Loss Sales Growth and Market Dynamics

Contradiction on the characterization of the competitive environment and sales momentum.

Mike Ward (UBS) - Mike Ward (UBS)

2026Q2: The company remains disciplined in pricing and underwriting... The hard market and differentiated health solutions are positioning Sun Life well for the long term. The 1-1-25 cohort is 97% complete and in line with expectations, and the company is seeing improved pricing on new business. - David (U.S. Business Leader)

Could you discuss the stop-loss sales results and characterize the competitive environment, including whether the hard market makes it easier to win new business? - Nicolas Lu (Evercore)

2026Q2: Stop-loss sales growth (+86%) is driven by... a hardening market. Sales in H1 2025 were lower due to competitive pressures, but the market has since hardened. - David (U.S. Business Leader)

Contradiction Point 3

U.S. Dental Strategy and Medicaid Business Outlook

Contradiction on the severity and outlook for the dental Medicaid business.

Gabrielle Deschain (National Bank) - Gabrielle Deschain (National Bank)

2026Q2: The dental Medicaid business is a long-term struggle, with focus shifting to building the commercial side, which will take several years. - Kevin Strain(CEO)

Could you clarify the phrasing of "unfavorable experience due to seasonal reserve build" in the stop-loss business and provide details on the remaining Medicaid business to shed in the dental segment, including the timeline? - Gabriel Dechaine (National Bank)

2026Q1: The loss ratio is improving, but the environment remains pressured. Continued improvement is expected in the second half of the year, with actions focused on long-term reasonable margins. - David Moffat(Executive)

Contradiction Point 4

Nature of U.S. Earnings Growth

Contradiction on the primary driver of a step-function earnings increase.

What are Doug Young's insights on Desjardins' earnings performance? - Doug Young (Desjardins)

2026Q2: The positive insurance experience in Q2 was driven by about a third from mortality and two-thirds from morbidity... Over the past eight quarters, Canada has averaged a positive insurance experience of about $57 million pre-tax per quarter, which is considered sustainable. - Jessica(Executive)

In Canada, how would you assess this quarter's performance, which was favorable but not as strong as previous periods, and is the division's apparent outperformance sustainable? - Paul Holden (CIBC)

2026Q1: The step-function improvement in underlying earnings and surplus was primarily driven by trading gains, which are not recurring. - Brennan Kennedy(Executive)

Contradiction Point 5

U.S. Stop-Loss Experience and Reserve Expectations

Contradiction on whether recent experience was expected or indicative of a shift.

Gabrielle Deschain (National Bank) - Gabrielle Deschain (National Bank)

2026Q2: The Q2 stop-loss results include known seasonality from the buildup of IBNR reserves, which is considered ‘unfavorable but expected.’ The experience was in line with expectations, with loss ratios remaining stable in the mid-70s. - David (U.S. Business Leader)

Was the "unfavorable experience due to seasonal reserve build" in the U.S. stop-loss business due to an unexpected variance versus normal practices? - Darko Mihelic (RBC Capital Markets)

2025Q4: The loss ratio for the 1/1/25 cohort was marginally improved in Q4 but almost identical to the Q3 projection. No change to reserving methodologies. - David (U.S. Business Leader)